GleamWall
中文EN

HAE HAEMONETICS CORP

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 313143 · Fiscal year ends 04/03

Financial factors as of 2026-09-26 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.1%
TTM net income YoY-38.2%
TTM EPS YoY-33.9%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR-6.8%

Margins

Gross margin59.6%
Operating margin12.8%
Net margin7.5%
FCF margin21.6%
EBITDA margin20.7%

Returns

ROE11.9%
ROA4.3%
ROIC (approx.)7.3%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets62.7%
Debt / equity1.25x
Current ratio2.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.32x
Accruals ratio-9.9%
Payout ratio—
Capex / revenue3.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-262027Q12026-06-272026Q4*2026-03-282026Q32025-12-272026Q22025-09-272026Q12025-06-282025Q4*2025-03-292025Q32024-12-28
Income statement
Revenue$357.76M$339.38M$346.35M$338.97M$327.31M$321.39M$330.60M$348.54M
Cost of revenue$136.85M$136.58M$148.14M$136.58M$132.57M$129.15M$137.55M$155.00M
Gross profit$220.91M$202.80M$198.21M$202.39M$194.74M$192.24M$193.05M$193.55M
R&D expense$17.03M$16.20M$14.45M$14.19M$14.87M$16.26M$15.91M$15.83M
SG&A expense$118.36M$118.94M$120.93M$109.15M$101.61M$110.72M$115.14M$106.46M
Operating income$75.12M$57.46M-$23.02M$67.40M$58.49M$53.87M$71.33M$59.03M
Pretax income$62.86M$47.57M-$28.40M$59.98M$51.28M$45.17M$70.74M$49.92M
Income tax$16.55M$14.56M-$8.25M$15.23M$12.60M$11.14M$12.76M$12.42M
Net income$46.30M$33.01M-$20.15M$44.74M$38.68M$34.03M$57.98M$37.49M
EBITDA$102.88M$84.57M$4.29M$94.78M$86.75M$82.63M$99.54M$88.05M
EPS (basic)1.020.73—0.960.810.71—0.75
EPS (diluted)1.000.72—0.950.810.70—0.74
Weighted avg. shares (diluted)46.46M45.70M—46.99M47.66M48.35M—50.64M
Balance sheet
Cash & equivalents$260.71M$223.38M$245.44M$363.37M$296.43M$292.90M$306.76M$320.85M
Receivables$224.95M$216.07M$216.85M$195.71M$207.07M$200.75M$202.66M$211.95M
Inventory$305.01M$306.74M$306.37M$321.19M$336.21M$360.53M$365.14M$359.61M
Current assets$855.53M$810.83M$834.88M$943.67M$899.68M$913.16M$934.98M$1.01B
PP&E, net$307.92M$303.78M$305.76M$297.23M$292.48M$286.87M$284.05M$286.11M
Goodwill$657.10M$656.88M$656.37M$606.83M$606.10M$607.30M$604.27M$605.27M
Intangibles$426.36M$434.51M$447.65M$419.73M$428.36M$450.63M$455.74M$465.62M
Total assets$2.41B$2.37B$2.40B$2.49B$2.44B$2.46B$2.45B$2.53B
Current liabilities$300.84M$263.24M$282.60M$539.87M$548.32M$531.41M$578.11M$253.23M
Short-term debt$9.64M$4.96M$5.01M$304.75M$304.33M$303.95M$303.56M$5.08M
Long-term debt$1.11B$1.17B$1.22B$919.99M$920.39M$920.83M$921.23M$1.22B
Total debt$1.12B$1.17B$1.22B$1.22B$1.22B$1.22B$1.22B$1.22B
Total liabilities$1.51B$1.53B$1.60B$1.58B$1.59B$1.58B$1.63B$1.62B
Shareholders' equity$898.50M$837.10M$796.32M$911.45M$849.17M$882.30M$820.84M$906.86M
Net debt$863.05M$950.77M$979.14M$861.37M$928.30M$931.88M$918.02M$903.99M
Shares outstanding45.52M45.47M45.25M46.83M46.75M48.16M48.22M50.24M
Cash flow statement
Operating cash flow$128.10M$52.32M$70.94M$93.56M$111.32M$17.39M$116.56M$43.77M
Capital expenditure$14.77M$7.91M$17.66M$6.35M$5.02M$3.75M$15.64M$8.55M
Free cash flow$113.33M$44.42M$53.28M$87.22M$106.31M$13.64M$100.91M$35.22M
Investing cash flow-$24.29M-$22.23M-$86.61M-$29.47M-$30.47M-$33.00M$18.04M-$17.37M
Financing cash flow-$67.61M-$51.53M-$101.50M$2.03M-$76.55M-$2.44M-$151.45M$1.38M
Depreciation & amortization$27.76M$27.11M$27.32M$27.39M$28.25M$28.76M$28.21M$29.02M
Stock-based compensation$10.23M$9.31M$9.13M$7.80M$7.59M$9.31M$6.94M$8.21M
Share buybacks——$100.00M$0——$150.00M$0

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.